Breakthrough SARS-CoV-2 Infections after Vaccination in North Carolina. (Record no. 107)

MARC details
000 -LEADER
fixed length control field 02076nam a22003497a 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 221213s20222022 xxu||||| |||| 00| 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 2076-393X
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code 10.3390/vaccines10111922 [doi]
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code PMC9695352 [pmc]
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code vaccines10111922 [pii]
040 ## - CATALOGING SOURCE
Original cataloging agency Ovid MEDLINE(R)
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC)
PMID 36423018
245 ## - TITLE STATEMENT
Title Breakthrough SARS-CoV-2 Infections after Vaccination in North Carolina.
251 ## - Source
Source 101629355. 10(11), 2022 Nov 13.
252 ## - Abbreviated Source
Abbreviated source Vaccines (Basel). 10(11), 2022 Nov 13.
253 ## - Journal Name
Journal name Vaccines
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Year 2022
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Manufacturer FY2023
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Publication date 2022 Nov 13
265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE]
Publication status epublish
266 ## - Date added to catalog
Date added to catalog 2022-12-13
520 ## - SUMMARY, ETC.
Abstract We characterize the overall incidence and risk factors for breakthrough infection among fully vaccinated participants in the North Carolina COVID-19 Community Research Partnership cohort. Among 15,808 eligible participants, 638 reported a positive SARS-CoV-2 test after vaccination. Factors associated with a lower risk of breakthrough in the time-to-event analysis included older age, prior SARS-CovV-2 infection, higher rates of face mask use, and receipt of a booster vaccination. Higher rates of breakthrough were reported by participants vaccinated with BNT162b2 or Ad26.COV2.S compared to mRNA-1273, in suburban or rural counties compared to urban counties, and during circulation of the Delta and Omicron variants.
546 ## - LANGUAGE NOTE
Language note English
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element IN PROCESS -- NOT YET INDEXED
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME
Institution MedStar Health Research Institute
657 ## - INDEX TERM--FUNCTION
Medline publication type Journal Article
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Miller, Kristen
Institution Code MHRI
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Weintraub, William S
Institution Code MHRI
790 ## - Authors
All authors Ahmed A, Berry AA, Bott M, Burke B, Edelstein SL, Fette LM, Gunaratne M, Herrington D, Keating J, Lagarde WH, Miller K, Munawar I, On Behalf Of The Covid-Community Research Partnership, Runyon MS, Sanders JW, Santacatterina M, Schieffelin J, Seals AL, Strylewicz G, Tapp H, Uschner D, Weintraub WS, Yukich J
856 ## - ELECTRONIC LOCATION AND ACCESS
DOI <a href="https://dx.doi.org/10.3390/vaccines10111922">https://dx.doi.org/10.3390/vaccines10111922</a>
Public note https://dx.doi.org/10.3390/vaccines10111922
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Journal Article
Item type description Article
Holdings
Withdrawn status Lost status Damaged status Not for loan Collection Home library Current library Date acquired Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
          MedStar Authors Catalog MedStar Authors Catalog 12/13/2022   36423018 36423018 12/13/2022 12/13/2022 Journal Article

Powered by Koha